Janoshik Analytical Review: The Story Behind the Gray Market's Most Trusted Peptide Testing Lab

In an industry with no FDA oversight, no mandatory testing, and no accountability for vendors who sell mislabeled or contaminated products, one name comes up more than any other when the peptide community talks about trust: Janoshik Analytical.

Based in Prague, Czech Republic, this independent testing laboratory has quietly become the closest thing the gray market has to a quality control system. Vendors post Janoshik results to build credibility. Buyers demand Janoshik COAs before purchasing. Chinese manufacturers honor guarantee claims only when backed by Janoshik testing. And when a vendor gets caught selling fake or underdosed product, it is almost always a Janoshik test that pulled the trigger.

But who is actually behind the lab? How did a former amateur weightlifter from Slovakia build the most trusted testing operation in an unregulated global market? And does the trust hold up under scrutiny?

This is the full story.

Who Is Janoshik? The Founder Behind the Lab#

The name "Janoshik" is not a corporate brand invented by a marketing team. It derives from Janosik — a legendary folk hero of Slovak national mythology, a Robin Hood figure who robbed from the rich and gave to the poor. The man behind the lab adopted it as an online pseudonym years ago on anonymous bodybuilding boards, and it stuck.

His real name is Peter Magic, a former amateur weightlifter from Slovakia. The company's leadership team, per their About page, includes:

• Peter Magic — Owner & CEO
• Edita Prokesova — Chief Scientific Officer (CSO)
• Jakub Dobrik — Managing Director & CFO

Peter's path to running a peptide testing empire started in the most relatable way possible: he was tired of friends getting scammed.

Around 2012–2013, the underground steroid market was rampant with counterfeits. Friends in Peter's weightlifting community were "plagued by fake gear" — paying for testosterone that contained vegetable oil, or trenbolone that was actually testosterone propionate at a fraction of the dose. The existing options for independent testing were essentially nonexistent for individual consumers.

Peter started offering HPLC testing as a service. Word spread through forums. Demand grew. What began as a favor for friends scaled into a full-time operation. The company was formally registered as Janoshik s.r.o. in Prague, Czech Republic, on October 25, 2022, though the testing services had been running for nearly a decade before formal incorporation.

Today, the lab employs approximately 30 staff members and processes hundreds of tests per day. Peptide testing alone accounts for roughly 100 tests daily, with GLP-1 agonists like semaglutide and tirzepatide comprising 70–80% of peptide volume — a reflection of the explosive growth in gray market GLP-1 demand.

From Steroids to Peptides: How the Lab Evolved#

Janoshik's origin story is rooted in the anabolic steroid community, not peptides. For most of its first decade, the lab's bread and butter was testing underground lab (UGL) testosterone, trenbolone, nandrolone, and other anabolic compounds. The bodybuilding forums — MESO-Rx, Eroids, Brotherhood of Pain, Canadian Brawn — were the primary channels.

The pivot to peptides accelerated around 2023–2024, driven by several converging forces:

• The explosion of gray market semaglutide and tirzepatide demand as GLP-1 medications went mainstream for weight loss
• China's intermittent crackdowns on raw steroid powder exports, which disrupted the traditional UGL supply chain
• Growing awareness that peptide quality was wildly inconsistent — a problem that testing could address

Peter Magic discussed this shift in his October 2025 appearance on the "Drugs n Stuff" podcast (Episode 285) with Scott McNally and Dave Crosland, titled "The Steroid Market Has Collapsed." The episode documented how Janoshik's data reveals the deteriorating state of underground steroid quality while the peptide market surges.

The lab now offers testing for both compound classes, but peptides have become the dominant revenue driver.

The Business Model: Simple and Transparent#

One of the reasons Janoshik has maintained trust is the simplicity of its business model. Unlike platforms that rate vendors publicly while also collecting revenue from those vendors, Janoshik operates on a straightforward fee-for-service basis:

You send a sample. You pay. You get results.

There is no vendor rating system. There is no public leaderboard. There are no "premium vendor" tiers. The customer who submits the sample receives the results. What they do with those results — post them publicly, share them privately, or keep them to themselves — is entirely their choice.

Current Pricing#

Payment accepts standard currency — cryptocurrency is accepted but not required, despite a common misconception. Group testing orders are available by emailing with "Group testing" as the subject.

Why This Model Matters#

The structural simplicity is the point. When a lab has no rating system, there is no rating to manipulate. When a lab has no vendor partnership program, there is no paid tier to create preferential treatment. When the customer — not the vendor — is the paying client, the lab's financial incentive aligns with delivering accurate results to the person who paid.

This stands in contrast to models where the testing organization generates revenue from the entities being rated, which creates structural conflicts we have examined elsewhere.

What Janoshik Tests and How#

Janoshik uses High-Performance Liquid Chromatography (HPLC) as its primary analytical method, coupled with UV detection for quantification. Mass spectrometry variants (LC-MS and GC-MS) provide identity confirmation and contamination screening.

Testing Capabilities#

• HPLC Purity — Quantifies the percentage of the target compound versus impurities
• LC-MS/MS Identity — Confirms the molecular identity of the compound via mass spectrometry
• Endotoxin (LAL) — Bacterial endotoxin testing for injectable samples
• Heavy Metals (ICP-MS) — Screens for metal contamination
• Sterility (TAMC + TYMC) — Total aerobic microbial count and yeast/mold count
• Residual Solvents (GC-MS) — Detects leftover manufacturing solvents

Error margins are typically 5% for oils and oral compounds, up to 10% for liquid suspensions and specific compounds like clenbuterol.

Blind Testing#

One of Janoshik's strongest trust signals is blind testing accuracy. Community members have repeatedly validated this by sending mislabeled or unlabeled samples to see if the lab correctly identifies them.

The most frequently cited case: a user known as Roy sent Janoshik a blind mix of three testosterone compounds — Enanthate, Cypionate, and Propionate at 80mg/80mg/40mg respectively. Janoshik returned results identifying every compound and dosage correctly despite having no information about what the vial contained.

Multiple users on UK-Muscle have reported "deliberately mis-labelling products, and he always gets it right." This kind of community-driven validation is rare in any industry, let alone an unregulated one.

The COA Verification System#

Every Janoshik Certificate of Analysis includes a unique key and QR code that can be verified on their public database at public.janoshik.com. This system serves two purposes:

1. Consumers can verify that a COA a vendor shows them is real and unaltered
2. Forgeries are detectable — altered COAs will not match the database entry

This system has directly caught vendors committing fraud. In the Modern Peptides case on GLP-1 Forum, a vendor posted a NAD+ COA with the Janoshik key and QR code removed. When Janoshik investigated, the test number actually corresponded to "QSC BAC water" — bacteriostatic water, a completely different product. The vendor had taken a real Janoshik COA for a different product and doctored it.

Peter Magic's response to the vendor was characteristically direct: "Could you please respectfully explain what the fuck this is, Mr. Steiner?"

The vendor threatened legal action rather than addressing the fraud.

The 43% Failure Rate: Janoshik's Biggest Finding#

Perhaps the most important data point Janoshik has produced is this: 43% of peptides tested in 2024 failed to meet label purity claims.

This finding, cited by The Peptide List's investigation, broke down along vendor tiers. Lower-tier vendors (Tier 3 and 4) showed actual purities of 71–91% despite claiming 99%+. Even supposedly reputable vendors occasionally fell short.

The implications are stark. If you are purchasing peptides from the gray market without independent testing, there is roughly a coin flip's chance that what you received does not match what the label says. The compound might be impure. It might be underdosed. In some cases — as Janoshik testing has documented — it might be an entirely different molecule.

This is not theoretical. Specific cases Janoshik testing has exposed include:

• Coastal Peptides: Samples labeled as semaglutide actually contained cagrilintide — a different peptide entirely. Janoshik was among the labs that correctly identified the mislabeling while another lab (Chromate) initially missed it
• Modern Peptides: Forged Janoshik COAs to create the appearance of testing that never occurred
• PSL (Peptide Sciences): A product sold as Primo-E (primobolan enanthate) tested as testosterone propionate — a far cheaper compound sold at the premium primobolan price point
• Tier 4 vendor semaglutide fraud: Mass spectrometry showed a molecular weight of 2847 Da versus the expected 4113 Da for semaglutide — confirming the sample was not semaglutide at any purity level
• YourMuscleShop: Testing revealed products that were "way underdosed," prompting the vendor to discontinue the affected batch

These cases illustrate why independent testing matters. Without Janoshik (or a comparable lab), every one of these products would have been injected by consumers who had no way to know what they were actually receiving.

Why the Community Calls Janoshik the Gold Standard#

The "gold standard" label did not come from Janoshik's marketing. It emerged organically from forum discussions across Reddit, MESO-Rx, GLP-1 Forum, The Iron Den, UK-Muscle, and dozens of other communities. The reasons are consistent:

1. Longevity#

Over a decade of continuous operation. In a space where testing services appear and disappear regularly, simply surviving this long while maintaining a consistent reputation is itself a signal.

2. Chinese Vendor Recognition#

This is one of the more unusual trust indicators. According to community reports, Chinese peptide and steroid manufacturers honor guarantee claims only when backed by Janoshik testing. The manufacturers themselves — the upstream source for most gray market products — consider Janoshik results authoritative. When the supply chain trusts the tester, that carries weight.

3. Community Accessibility#

Peter Magic is not a faceless corporate entity. He participates actively on forums (the MESO-Rx Janoshik thread spans 67+ pages), does podcast interviews, and responds to community questions. His podcast appearances include:

• Daniel Pekic interview (YouTube) — Deep dive on peptides, purity, and motivations
• "Gear, Growth, and Gains" with Type-IIx (Episode 17, October 2025) — Counterfeit steroids, bribery allegations, SLU-PP-332 misconceptions
• "Drugs n Stuff" with Scott McNally and Dave Crosland (Episode 285, October 2025) — "The Steroid Market Has Collapsed"
• GLP-1 Forum feature interview — "Peptide Myths Busted: Janoshik Founder Sets the Record Straight"

4. Harm Reduction Value#

As GLP-1 Forum user exploitedworkerbee noted, Janoshik is "the only lab licensed to work with many of these substances," operating transparently in the Czech Republic with full regulatory compliance. In a market where consumers are self-injecting compounds with no quality assurance, any reliable testing reduces the risk of harm.

5. The Verification System#

The QR-coded COA system is a practical innovation that serves the community's needs directly. It transforms a Janoshik COA from a static document (which can be forged) into a verifiable digital record (which cannot be forged without being detected). As GLP-1 Forum staff member ZippityDooDah noted: "It's rare for an altered test report to still include a valid QR code."

The Criticisms: Where Janoshik Falls Short#

Trust does not mean infallibility. Janoshik has legitimate weaknesses that the community acknowledges, even as they continue to use the service.

No ISO 17025 Accreditation#

This is the most persistent and substantive criticism. ISO/IEC 17025 is the internationally recognized standard for testing and calibration laboratory competence. It specifies requirements for competence, impartiality, and consistent operation. In most regulated industries, results from non-accredited labs are not accepted by regulators or suppliers.

Janoshik does not hold this accreditation. This means:

• Results are not suitable for regulatory submissions — they would not be accepted by the FDA, EMA, or any pharmaceutical regulatory body
• There is no external audit of Janoshik's testing procedures, equipment calibration, or quality systems
• COAs lack methodology details — they do not specify what column, solvent system, or gradient was used for HPLC analysis
• Raw chromatographic data is behind a paywall — you see the result, not the underlying evidence

Critics on PED Test Australia framed this bluntly: Janoshik "is not an accredited testing laboratory and conforms to no basic standards" with "certificates of analysis [that] don't even list what tests were performed."

This criticism is valid. But it also applies to essentially every testing service operating in the gray market space. No gray market testing lab — not Janoshik, not Chromate, not Krause Analytical, not peptidetest.com — holds ISO 17025 accreditation for the specific peptide assays performed. The accreditation gap is an industry-wide problem, not a Janoshik-specific one.

Documented Accuracy Issues#

Janoshik is not infallible, and honesty requires acknowledging the documented failures:

The drostanolone incident (Brotherhood of Pain): During a vetting process, drostanolone enanthate samples from a specific batch (February 14–17) tested approximately 15% under their actual content. The cause was identified as either an assistant weighing the reference standard incorrectly or an issue with the standard itself. The error was identified, acknowledged, and corrected — but it happened.

The unreceived sample allegation (SteroidSourceTalk): Critics claimed Janoshik provided "content/dimerization results on a sample he never received." If true, this would be a serious integrity issue. The claim has been disputed but never definitively resolved.

The credentials incident (Canadian Brawn): Peter Magic acknowledged placing intentionally false information about credentials as what he described as a "joke." User WuTang called him "a self admitted liar." While the community was divided — some saw competitive sabotage, others saw a genuine lapse in judgment — it damaged trust with a subset of users.

The Vendor-as-Client Conflict#

While Janoshik's model is structurally simpler than rating-platform models, it is not free of conflicts. Vendors are significant customers. They submit large numbers of samples at $120–$300+ per test. The question — would Janoshik really give unfavorable results to a high-volume paying client? — is legitimate.

Peter Magic addressed this directly in his October 2025 "Gear, Growth, and Gains" podcast appearance, where he "laughed off" bribery allegations. The community's response has generally been to accept his denial based on the broader evidence: Janoshik has published unfavorable results for many vendors, including large ones, and the blind testing validation makes systemic fabrication difficult to sustain.

But the conflict exists structurally. It is mitigated by the lab's reputation — losing credibility would destroy the business — but it is not eliminated by any formal safeguard like an independent review board or conflict of interest policy.

Cherry-Picked Public Results#

Janoshik's public database contains results that vendors and customers choose to make public. As GLP-1 Forum staff member ZippityDooDah critically noted: "Since that is a paid option (basically advertising), they are all cherry-picked results."

This means the public database does not represent a random sample. Vendors post their best results. Poor results stay private. The public database is useful for verifying that a specific COA is genuine, but it should not be interpreted as a comprehensive vendor quality assessment.

User YoYoFat captured the pragmatic response: "You have to test your batch. That's the only way to have any reasonable reliability."

The 2026 Data Breach#

In February 2026, Janoshik experienced a data breach. Customer shipping information and database contents were reportedly exposed. Attackers attempted extortion.

Community reaction on Anabolic Steroid Forums was swift:

• Captain_Furious raised concerns about "shipping info...sensitive information from their database"
• heavydutygorilla warned that attackers could "resell stolen data on dark web markets or target high-value customers like pharmaceutical sources"
• Community advice shifted toward using alternative identities, cash payments, and mail drops for future orders

Janoshik released an official statement via email, but the incident highlighted an inherent trade-off: submitting physical samples to any third-party lab requires providing real shipping information, which creates a data security risk that no amount of testing accuracy can mitigate.

For a community that already operates in legal gray areas, this kind of data exposure is not merely an inconvenience — it is a potential safety issue.

Peter Magic's Technical Positions: Myth-Busting From the Lab#

One of the reasons Janoshik has built community trust extends beyond testing results. Peter Magic regularly weighs in on technical questions that affect how consumers handle peptides, and his positions — informed by tens of thousands of tests — often challenge conventional community wisdom.

From interviews and forum posts, his key positions include:

• Bacteriostatic water is not always necessary — sterile water works for most peptide applications, contrary to the popular belief that BAC water is mandatory
• Properly lyophilized peptides remain stable for years refrigerated, over a decade frozen — far longer than the community typically assumes
• Shaking or injecting water directly into vials does NOT damage peptides — the conventional wisdom about gentle swirling being required is, per Janoshik's testing data, unfounded
• Room temperature degradation is typically minimal at 2–3%, not the catastrophic degradation community myths suggest
• Endotoxin contamination is extremely rare — approximately 3–5% sterility failures but endotoxin specifically is uncommon
• Reconstituted peptides should be used within approximately 4 weeks under refrigeration

These positions, shared in the GLP-1 Forum interview "Peptide Myths Busted", carry weight precisely because they come from someone with direct laboratory data rather than theoretical speculation or recycled forum wisdom.

Janoshik's Academic and Media Footprint#

Janoshik has crossed from underground reputation into broader recognition:

Academic citation: A ScienceDirect paper titled "Associations between anabolic-androgenic steroid testing, healthcare access and undesirable effects among international consumers" specifically mentions Janoshik Analytical as a drug checking service used by AAS consumers, analyzing data from 854 respondents in the 2024 Global Drug Survey.

ChinaTalk: An article on Chinese peptide supply chains referenced Janoshik's public database as providing crucial visibility in a supply chain where "between a synthesis reactor and research bench, peptides pass through intermediaries, repackagers, and distributors who may not maintain quality standards."

SF Standard: The September 2025 article "Everyone has a Chinese peptide dealer now" referenced Janoshik-sourced data on peptide quality issues in the gray market.

Rapamycin News: The longevity-focused community published a detailed profile of Peter Magic, drawing from his forum posts and podcast appearances.

Grokipedia: Janoshik Analytical has its own wiki-style entry documenting the lab's history, operations, and community reception.

This media footprint — spanning academic journals, mainstream tech publications, and niche community platforms — is unusual for a lab that started as one person testing steroids for friends.

Janoshik vs. Other Labs: How They Compare#

The gray market testing landscape has expanded, but Janoshik remains the reference point against which others are measured.

The Gray Market investigation by Rory provided the most rigorous direct comparison. When four identical retatrutide vials from the same batch were tested across labs:

• Janoshik: ~30mg (consistent across 9 vials)
• Chromate: 30mg (consistent with Janoshik)
• Krause Laboratories: 26mg (15% lower than every other lab)

The consistency of Janoshik's results across nine separate vials — all falling in the same range — is itself a data point about reproducibility.

Chromate has also had identification failures. In the Coastal Peptides case, Chromate initially failed to identify that samples labeled as semaglutide actually contained cagrilintide. Janoshik, MZ Biolabs, and TrustPointe all caught the error. Chromate issued corrected COAs months later.

The domestic shipping advantage of US-based labs is real and significant — $50–75 and customs risk eliminated versus international shipping to Prague. For routine testing, a US-based lab may be more practical. But for results where accuracy is paramount, the community consensus consistently points back to Janoshik.

The Paradox: Trust Without Verification#

Janoshik occupies a unique and paradoxical position. The lab is the community's primary tool for verifying vendor claims — but there is no comparable mechanism for verifying Janoshik's claims.

There is no ISO 17025 audit. There is no independent oversight board. There is no regulatory body reviewing their procedures. The trust is built on:

• Consistency over time — a decade of results that align with each other and with reality
• Blind testing validation — community members proactively testing the tester
• Vendor behavior — manufacturers adjusting their practices based on Janoshik results, which would not happen if the results were fabricated
• Cross-lab consistency — where direct comparisons exist, Janoshik's results tend to align with other credible labs

This is not the same as institutional verification. It is more like the trust model of a long-standing local business — earned through repeated positive experiences, not certified by an external authority.

The community's pragmatic assessment, captured by GLP-1 Forum user YoYoFat, remains the most honest framing: "You have to test your batch. That's the only way to have any reasonable reliability."

Janoshik does not eliminate the need for caution. It makes informed caution possible.

Should You Use Janoshik Analytical?#

For consumers navigating the gray market peptide space, Janoshik is the strongest available option for independent testing, with important caveats:

Use Janoshik when:

• You need to verify a vendor's claims about purity, identity, or potency before injecting a compound
• You want to confirm that a COA a vendor provided is genuine (use the QR verification system)
• You are part of a group buy and want collective quality assurance
• You are testing GLP-1 peptides where the financial stakes (these are expensive compounds) justify the testing cost

Understand the limitations:

• Results are not regulatory-grade and would not be accepted by the FDA or any pharmaceutical authority
• The lab is not ISO 17025 accredited, and COAs lack detailed methodology
• Raw chromatographic data requires additional payment to access
• International shipping adds cost ($50–75) and introduces customs risk
• The February 2026 data breach means your shipping information may have been exposed — consider using a mail drop or alternative address
• No single lab is infallible — for high-stakes decisions, consider testing the same sample at two independent labs

The bottom line: Janoshik is not a perfect lab. It is the most trusted lab in an imperfect market. Those are different statements, and the distinction matters.

For more context on how to evaluate any peptide testing lab, including red flags to watch for, see our peptide safety checklist and our peptide quality and purity guide.

Summary: The Case for and Against Janoshik#

The Bull Case#

• 10+ years of consistent operation with community-validated blind testing accuracy
• Simple fee-for-service model with no vendor rating system to create conflicts
• QR-verified COAs that have directly caught vendor fraud
• Recognition by Chinese manufacturers as the authoritative testing standard
• The 43% peptide failure rate finding — essential public health data that benefits the entire community
• Accessible founder who engages with the community through forums, podcasts, and interviews

The Bear Case#

• No ISO 17025 accreditation — results are not regulatory-grade
• COAs lack methodology details and raw data requires extra payment
• Documented accuracy failures (drostanolone incident, unreceived sample allegations)
• Peter Magic's acknowledged credibility lapse (the "joke" about credentials)
• Vendor-as-client conflict exists structurally even if not demonstrably acted upon
• Public database is cherry-picked by vendors — not a representative sample
• February 2026 data breach exposed customer personal information

The Community Equilibrium#

The community has landed on a pragmatic middle ground that acknowledges both cases. Janoshik is "the best available option" in a market with no better alternatives — not a replacement for pharmaceutical-grade quality control, but the most reliable approximation that individual consumers can access.

The advice that emerges from every forum, every thread, and every experienced community member is the same: test your own batch, verify your own results, and never trust any single source — including Janoshik — as infallible.

That is not a criticism of Janoshik. It is the appropriate level of epistemic humility for navigating a market that exists outside regulatory frameworks. And it is advice that Janoshik's own data — showing 43% of peptides failing quality standards — emphatically supports.

---

Disclosure: Peptide Protocol Wiki has no financial relationship with Janoshik Analytical, Peter Magic, or any testing laboratory mentioned in this article. We do not accept payment from vendors or labs for editorial coverage. All research was conducted using publicly available sources including company websites, community forums, podcast interviews, academic publications, and independent journalism.